ABOUT
Dr. Ken Sharlin, M.D., M.P.H., IFMCP
Dr. Kenneth S. Sharlin is a board-certified neurologist, researcher, teacher, author, and speaker, dedicated to transforming the landscape of neurological care through functional and regenerative strategies, advanced diagnostics, and emerging treatments that go beyond symptom management to achieve true disease reversal.
With over 25 years of experience in neurology, Dr. Sharlin seamlessly integrates conventional neurology, functional medicine, and cutting-edge regenerative therapies to provide a patient-centered approach to conditions such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, ALS, epilepsy, and chronic migraine.
His work is informed by a deep commitment to scientific innovation, clinical research, and evidence-based integrative medicine.
His research-backed approach to early Alzheimer’s diagnosis and intervention has been highlighted in publications such as Value in Identifying Preclinical Alzheimer’s Disease (Blood, 2024).
Beyond clinical practice, Dr. Sharlin leads Sharlin Health Neuroscience Research Center, a state-of-the-art clinical research facility conducting Phase II, III, and IV pharmaceutical-sponsored clinical trials.
His work with investigational drugs—including Immunic’s vidofludimus calcium, Eli Lilly’s Donanemab, and Novartis’ Ofatumumab—is helping to bring next-generation neurotherapeutics to market.
He has published extensively on biomarker-based precision neurology, including:
“A Blood Biomarker Test for Brain Amyloid Impacts the Clinical Evaluation of Cognitive Impairment” (Ann Clin Transl Neurol, 2023)
“Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the PrecivityAD2 Clinician Survey Study” (Diagnostics, 2025)
“Rapid and Sustained B-cell Depletion with Subcutaneous Ofatumumab in Relapsing Multiple Sclerosis: APLIOS, a Phase-2 Study” (Mult Scler, 2022)Bullet List 4
His research underscores his commitment to developing targeted, individualized therapies that address neurological disease at the root cause level.
As sought-after speaker for The American Academy of Anti-Aging Medicine, The Academy for Innovative & Preventative Medicine, and Integrative Medicine for Mental Health, Dr. Sharlin is committed to bridging the gap between the best of traditional neurology and pioneering, patient-centered treatments.
His work is not just about extending lifespan—it’s about improving healthspan, neurological resilience, and quality of life.
Dr. Sharlin’s mission is clear: to redefine how we diagnose, treat, and even reverse neurological disease through the fusion of clinical neurology, systems biology, functional and regenerative medicine.
Speaker For:
Podcast: Healthy Brain Tool Box
The Healthy Brain Toolbox:
Neurologist-Proven Strategies to Avoid Memory Loss and Protect Your Aging Brain
$18
Subscribe to the newsletter
Get the latest news and updates from Dr. Ken Sharlin, M.D.
© Dr. Ken Sharlin | All Rights Reserved | Privacy Policy